Related Experiment Videos
[HDL metabolism]
1Medizinische Klinik mit Schwerpunkt Gastroenterologie, Hepatologie und Endokrinologie, Campus Charité Mitte. janine.genschel@charite.de
Insights
High-density lipoproteins (HDL) are key in preventing cardiovascular disease by removing cholesterol. Understanding HDL metabolism is crucial for developing new therapies to manage lipid disorders and reduce heart disease risk.
Area of Science:
- Biochemistry
- Cardiovascular Medicine
- Metabolic Disorders
Context:
- Lipids and lipoproteins are primary risk factors for atherosclerosis and cardiovascular diseases.
- Metabolic disorders like diabetes and pancreatitis are linked to lipoprotein metabolism dysfunction.
- Epidemiologic studies show an inverse correlation between high-density lipoprotein (HDL) plasma concentration and cardiovascular disease risk.
Purpose:
- To detail the known factors influencing high-density lipoprotein (HDL) metabolism.
- To provide a comprehensive understanding of HDL metabolism for evaluating new therapeutic strategies.
- To highlight the role of HDL in reverse cholesterol transport and its implications for cardiovascular health.
Summary:
- High-density lipoproteins (HDL) play a critical role in reverse cholesterol transport, moving cholesterol from peripheral cells to the liver for excretion.
- Disruptions in lipoprotein metabolism can lead to serious health issues, including diabetes, pancreatitis, and premature atherosclerosis.
- Recent discoveries, such as the cholesterol efflux regulating protein, have advanced our understanding of HDL metabolism, though detailed mechanisms require further elucidation.
Impact:
- Enhanced understanding of HDL metabolism can inform the development of novel therapeutic strategies for managing dyslipidemias.
- Identifying factors that regulate HDL metabolism may lead to improved treatments for cardiovascular diseases.
- This knowledge is vital for evaluating interventions aimed at modulating serum HDL concentrations to mitigate cardiovascular risk.
Abstract:
Lipids and lipoproteins represent main risk factors for the development and the progress of atherosclerotic and cardiovascular diseases. Disorders in lipoprotein metabolism may result in diabetes mellitus, acute pancreatitis, and in the early occurrence of atherosclerotic alterations. The plasma concentration of high density lipoproteins (HDL) is inverse correlated with the risk of cardiovascular diseases as shown in epidemiologic studies. HDL play an important role in the reverse cholesterol transport. Free cholesterol from peripheral cells can be assembled in HDL particles, transformed to cholesterol esters, transported to the liver, and secreted via the bile as bile acids. The metabolism of HDL is not known in detail. Numerous factors were identified to influence the metabolism of HDL. Particularly the identification of the cholesterol efflux regulating protein adduced new insights in HDL metabolism. A detailed description of HDL metabolism is necessary for the evaluation of new therapeutic strategies for the regulation of the serum concentration of this important lipoprotein. Here we describe the known influencing factors for a better understanding of HDL metabolism.